Zahi Touma, MD, PhD, from the University Health Network in Toronto, and colleagues examined whether anifrolumab plus SOC is associated with reduced organ damage accumulation compared with SOC only ...

Mar. 13, 2025 — New research shows that people with eating disorders are more harshly judged than those suffering from depression, making it much harder for them to seek ... Worldwide Study ...

Investing during a period of economic depression or recession can be daunting. However, choosing the right depression stocks can help you weather a period of uncertainty and protect your financial ...

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity and remission, and more time spent in those states, vs. standard therapy ...

Repetitive transcranial magnetic stimulation is used to treat various neuropsychiatric but its considerable power consumption and large size limit its potential for broader utility. Here, the ...

Turns out a “Supernatural” reunion is happening after all — just for a completely different series. Amazon Prime Video’s hit (anti-) superhero series “The Boys” revealed Wednesday it ...

Saphnelo (anifrolumab) is the first biologic drug for SLE to be approved in Europe that is not restricted to patients with a high degree of disease activity, according to AZ, which also notes it ...

Emotional intelligence (EI) refers to a person’s ability to recognize and understand their own and others’ emotions and to manage their emotions to achieve specific goals. Whilst not always ...

"First indicators are dips and depression in the ground surfaces, deepening with tiny cracks in pavements or buildings for instance, leading to buildings showing slight movement," he said. However, ...

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients ...

Feeling down? Recent research from Harvard found that consuming a certain type of fruit can significantly lower your risk of depression. Here's how.